---
schema_version: "secwatch.filing_event.v1"
accession: "0001178913-25-002570"
form_type: "8-K"
ticker: "SLXN"
cik: "0002022416"
company_name: "Silexion Therapeutics Corp"
filed_at: "2025-08-01T23:59:59+00:00"
generated_at: "2026-05-17T21:57:57.495142+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Silexion exercises 152K warrants at $11.57 for ~$1.8M gross; issues new warrants

## Summary
- Exercises 152,106 existing warrants at $11.57/share; gross proceeds ~$1.8M before fees.
- Issues new warrants for up to 304,212 ordinary shares at $11.32/share; 24-month term from resale registration.
- Closing expected August 1, 2025; shareholder meeting August 12 for authorized share increase.
- H.C. Wainwright receives 7% cash fee, management fee, and warrants as placement agent.
- Company to file resale registration statement within 30 days; 15-day lock-up and 1-year variable rate transaction ban.

## SEC filing metadata
- accession: 0001178913-25-002570
- form_type: 8-K
- ticker: SLXN
- cik: 0002022416
- company_name: Silexion Therapeutics Corp
- filed_at: 2025-08-01T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/2022416/000117891325002570/0001178913-25-002570-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/2022416/000117891325002570/zk2533522.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001178913-25-002570
- JSON: https://secwatch.observer/filing/0001178913-25-002570.json
- Plain text: https://secwatch.observer/filing/0001178913-25-002570.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.